Agilent Technologies Inc
A146.360USD
+3.000+2.09%
Close 10/31, 16:00（ET）Quotes delayed by 15 min
41.51BMarket Cap
34.02P/E TTM
More Details of Agilent Technologies Inc Company
Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company’s life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the cell analysis, advanced manufacturing partnerships contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, genomics and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. It also offers contract development and manufacturing organization (CDMO) services.
Agilent Technologies Inc Info
Ticker SymbolA
Company nameAgilent Technologies Inc
IPO dateNov 18, 1999
CEOMr. Padraig Mcdonnell
Number of employees17900
Security typeOrdinary Share
Fiscal year-endNov 18
Address5301 Stevens Creek Blvd
CitySANTA CLARA
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code95051
Phone14083458886
Websitehttps://www.agilent.com/
Ticker SymbolA
IPO dateNov 18, 1999
CEOMr. Padraig Mcdonnell
Company Executives of Agilent Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.55K
+2.11%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Vice President, Corporate Controller, Principal Accounting Officer
Vice President, Corporate Controller, Principal Accounting Officer
48.45K
+22.91%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.35K
+4.98%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.68K
--
Ms. Angelica Riemann
Ms. Angelica Riemann
Senior Vice President, Agilent President, Agilent CrossLab
Senior Vice President, Agilent President, Agilent CrossLab
18.68K
-0.45%
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.04K
+11.21%
Ms. Mala Anand
Ms. Mala Anand
Independent Director
Independent Director
14.55K
+14.29%
Dr. Otis W. Brawley, M.D.
Dr. Otis W. Brawley, M.D.
Independent Director
Independent Director
10.73K
+32.49%
Dr. Mikael G. Dolsten, M.D., Ph.D.
Dr. Mikael G. Dolsten, M.D., Ph.D.
Independent Director
Independent Director
7.54K
+31.77%
Dr. Simon May
Dr. Simon May
Senior Vice President, Agilent President, Life Sciences and Diagnostics Markets Group
Senior Vice President, Agilent President, Life Sciences and Diagnostics Markets Group
7.32K
-4.79%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.55K
+2.11%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Vice President, Corporate Controller, Principal Accounting Officer
Vice President, Corporate Controller, Principal Accounting Officer
48.45K
+22.91%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.35K
+4.98%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.68K
--
Ms. Angelica Riemann
Ms. Angelica Riemann
Senior Vice President, Agilent President, Agilent CrossLab
Senior Vice President, Agilent President, Agilent CrossLab
18.68K
-0.45%
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.04K
+11.21%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Non-instrumentation and other
1.14B
65.54%
Instrumentation
599.00M
34.46%
By RegionUSD
Name
Revenue
Proportion
United States
683.00M
39.30%
Asia Pacific
563.00M
32.39%
Europe
492.00M
28.31%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Non-instrumentation and other
1.14B
65.54%
Instrumentation
599.00M
34.46%
Shareholding Stats
Updated: Tue, Oct 28
Updated: Tue, Oct 28
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.95%
BlackRock Institutional Trust Company, N.A.
5.24%
State Street Investment Management (US)
4.39%
MFS Investment Management
4.06%
Wellington Management Company, LLP
3.16%
Other
71.20%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.95%
BlackRock Institutional Trust Company, N.A.
5.24%
State Street Investment Management (US)
4.39%
MFS Investment Management
4.06%
Wellington Management Company, LLP
3.16%
Other
71.20%
Shareholder Types
Shareholders
Proportion
Investment Advisor
44.15%
Investment Advisor/Hedge Fund
35.90%
Hedge Fund
3.62%
Pension Fund
1.78%
Insurance Company
1.67%
Bank and Trust
1.58%
Research Firm
1.58%
Sovereign Wealth Fund
1.28%
Family Office
0.44%
Other
8.00%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
2069
259.83M
91.65%
-7.74M
2025Q2
2111
262.65M
92.46%
-3.65M
2025Q1
2174
262.93M
92.55%
-7.77M
2024Q4
2144
261.66M
91.77%
-9.44M
2024Q3
2092
261.54M
91.00%
-12.94M
2024Q2
2065
263.61M
90.36%
-18.36M
2024Q1
2066
270.62M
92.35%
-9.44M
2023Q4
2084
269.59M
92.01%
-3.30M
2023Q3
2017
262.63M
89.76%
-13.56M
2023Q2
2002
268.16M
90.78%
-20.64M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
33.87M
11.95%
+586.53K
+1.76%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
14.86M
5.24%
-507.73K
-3.30%
Jun 30, 2025
State Street Investment Management (US)
12.45M
4.39%
-155.76K
-1.24%
Jun 30, 2025
MFS Investment Management
12.19M
4.3%
+1.21M
+11.01%
Jun 30, 2025
Wellington Management Company, LLP
8.95M
3.16%
+16.40K
+0.18%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
8.16M
2.88%
+562.40K
+7.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
7.32M
2.58%
+115.18K
+1.60%
Jun 30, 2025
Generation Investment Management LLP
5.78M
2.04%
+792.30K
+15.90%
Jun 30, 2025
Pictet Asset Management Ltd.
4.77M
1.68%
-569.04K
-10.65%
Jun 30, 2025
State Farm Insurance Companies
4.52M
1.59%
--
--
Jun 30, 2025
View more
Related ETFs
Updated: Mon, Oct 6
Updated: Mon, Oct 6
Name
Proportion
Honeytree US Equity ETF
4.33%
First Trust Water ETF
3.6%
Goldman Sachs Future Health Care Equity ETF
3.14%
Madison Covered Call ETF
2.82%
VanEck Morningstar Wide Moat ETF
2.42%
First Trust Indxx Medical Devices ETF
2.29%
VanEck Morningstar Wide Moat Value ETF
2.28%
Invesco Raymond James SB-1 Equity ETF
2.22%
Global X Genomics & Biotechnology ETF
2.18%
Argent Mid Cap ETF
2.14%
View more
Honeytree US Equity ETF
Proportion4.33%
First Trust Water ETF
Proportion3.6%
Goldman Sachs Future Health Care Equity ETF
Proportion3.14%
Madison Covered Call ETF
Proportion2.82%
VanEck Morningstar Wide Moat ETF
Proportion2.42%
First Trust Indxx Medical Devices ETF
Proportion2.29%
VanEck Morningstar Wide Moat Value ETF
Proportion2.28%
Invesco Raymond James SB-1 Equity ETF
Proportion2.22%
Global X Genomics & Biotechnology ETF
Proportion2.18%
Argent Mid Cap ETF
Proportion2.14%
Dividend
A total of
1.25B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Nov 20, 2024
A.NB Interim Cash Dividend of gross USD 0.248 paid on Jan 22, 2025 going ex on Dec 31, 2024 with reinvestment option
Dec 31, 2024
Jan 22, 2025
Dec 31, 2024
Sep 18, 2024
A.NB Final Cash Dividend of gross USD 0.236 paid on Oct 23, 2024 going ex on Oct 01, 2024 with reinvestment option
Oct 01, 2024
Oct 23, 2024
Oct 01, 2024
May 22, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jul 24, 2024 going ex on Jul 02, 2024
Jul 02, 2024
Jul 24, 2024
Jul 02, 2024
Feb 21, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Apr 24, 2024 going ex on Apr 01, 2024
Apr 02, 2024
Apr 24, 2024
Apr 01, 2024
Nov 16, 2023
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jan 24, 2024 going ex on Dec 29, 2023
Jan 02, 2024
Jan 24, 2024
Dec 29, 2023
Sep 21, 2023
A.NB Final Cash Dividend of gross USD 0.225 paid on Oct 25, 2023 going ex on Oct 02, 2023 with reinvestment option
Oct 03, 2023
Oct 25, 2023
Oct 02, 2023
May 18, 2023
A.NB Interim Cash Dividend of gross USD 0.225 paid on Jul 26, 2023 going ex on Jun 30, 2023 with reinvestment option
Jul 03, 2023
Jul 26, 2023
Jun 30, 2023
Feb 22, 2023
A.NB Interim Cash Dividend of gross USD 0.225 paid on Apr 26, 2023 going ex on Apr 03, 2023
Apr 04, 2023
Apr 26, 2023
Apr 03, 2023
Nov 16, 2022
A.NB Interim Cash Dividend of gross USD 0.225 paid on Jan 25, 2023 going ex on Dec 30, 2022
Jan 03, 2023
Jan 25, 2023
Dec 30, 2022
Sep 21, 2022
A.NB Final Cash Dividend of gross USD 0.21 paid on Oct 26, 2022 going ex on Oct 03, 2022
Oct 04, 2022
Oct 26, 2022
Oct 03, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
